MedTrace Logo

Congestive Heart Failure Home Telemonitoring

NCT02048748 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2021-06-22

No results posted yet for this study

Summary

Remote monitoring of chronic heart failure can reduce deaths and hospitalisations, and may provide benefits on health care costs and quality of life. Currently there is limited use of remote monitoring for heart failure in Norway. The funding streams and the structure of the norwegian health service is different from other countries that have tried remote monitoring and therefore it is important to examine the utility of such services in Norway. The study is a randomised controlled trial that will allow participants in the intervention group to use a wireless weight scale and blood pressure monitor device that will send automatically the measurements electronically and securely to the Heart Failure Outpatient Clinic of the hospital.

Conditions

Interventions

DEVICE

Weight and blood pressure device

Weight and blood pressure device integrated in a home telemonitoring kit. The weight scale is Withings The Smart Bodyscale. The blood pressure device is MEDISANA iHealth BP3.

DEVICE

Home telemonitoring device

An iPad 2 WiFi 16GB (Model A1395) tablet integrating the telemonitoring kit.

Sponsors & Collaborators

  • Helse Nord

    collaborator INDUSTRY

  • University Hospital of North Norway

    lead OTHER

Principal Investigators

  • Artur Serrano, PHD · Norwegian Centre for Integrated Care and Telemedicine

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-02-28
Primary Completion
2015-01-31
Completion
2015-01-31

Countries

  • Norway

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02048748 on ClinicalTrials.gov